C. Pistore

DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells

M. Pelizzola, E. Giannoni, A. Weisz, 2017, Oncogene.

Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells

E. Monti, M. Gariboldi, E. Magnani, 2012, BMC Cell Biology.

Np95 is implicated in pericentromeric heterochromatin replication and in major satellite silencing.

R. Papait, I. M. Bonapace, C. Pistore, 2007, Molecular biology of the cell.

UHRF1 regulates CDH1 via promoter associated non-coding RNAs in prostate cancer cells.

S. Cogliati, E. Magnani, A. Dock-Brégeon, 2018, Biochimica et biophysica acta. Gene regulatory mechanisms.

The PHD domain of Np95 (mUHRF1) is involved in large-scale reorganization of pericentromeric heterochromatin.

H. Leonhardt, S. Cogliati, L. Brino, 2008, Molecular biology of the cell.

UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression

M. Ceccarelli, L. Altucci, A. Nebbioso, 2012, Oncogene.

The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression

R. Seiler, C. Catapano, L. Brino, 2012, Oncogene.